— Know what they know.
Not Investment Advice

PYPD NASDAQ

PolyPid Ltd.
1W: -0.6% 1M: -2.1% 3M: -7.0% YTD: +19.3% 1Y: +54.0% 3Y: -37.1% 5Y: -97.9%
$5.19
-0.18 (-3.35%)
 
Weekly Expected Move ±5.8%
$5 $5 $5 $5 $6
NASDAQ · Healthcare · Biotechnology · Tech Score Neutral · Power 43 · $99.0M mcap · 11M float · 1.68% daily turnover · Short 44% of daily vol

Balance Sheet Trends

Total Assets
$22M -11.6% ▼
5Y CAGR: -21.7%
Total Liabilities
$11M -35.4% ▼
5Y CAGR: +29.9%
Shareholders Equity
$11M +42.8% ▲
5Y CAGR: -31.5%
Cash & Investments
$13M -17.3% ▼
5Y CAGR: -21.9%
Total Debt
$3M -70.9% ▼
Net Debt
-$4M +40.1% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$10M$9M$6M$16M$6M
Short-Term Investments$22M$4M$0$0$7M
Cash & ST Investments$32M$13M$6M$16M$13M
Net Receivables$118K$298K$0$0$0
Inventory$0$0$0$0$1M
Other Current Assets$993K$750K$106K$602K$193K
Total Current Assets$35M$14M$6M$17M$15M
Property, Plant & Equip.$9M$12M$9M$8M$7M
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$663K$99K$87K$277K$311K
Total Non-Current Assets$9M$12M$9M$9M$7M
Total Assets$44M$26M$15M$25M$22M
— Liabilities —
Accounts Payable$4M$1M$772K$2M$3M
Short-Term Debt$0$4M$4M$7M$988K
Deferred Revenue$269K$0$0$0$0
Other Current Liabilities$0$16K$1M$23K$0
Total Current Liabilities$8M$9M$7M$13M$8M
Long-Term Debt$0$8M$6M$634K$0
Other Non-Current Liab.$199K$294K$398K$396K$3M
Total Non-Current Liabilities$199K$12M$10M$5M$4M
Total Liabilities$8M$20M$17M$18M$11M
— Equity —
Common Stock$0$0$0$0$0
Retained Earnings-$175M-$214M-$238M-$267M-$302M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$36M$6M-$2M$8M$11M
Total Liabilities & Equity$44M$26M$15M$25M$22M
— Key Metrics —
Total Debt$0$14M$12M$10M$3M
Net Debt-$10M$5M$6M-$6M-$4M
Total Investments$22M$4M$0$0$7M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms